Citation: | HU Shihao, YU Xinyue, LI Ruiting, WU Xiaoxia, YANG Xuping, HAN Zhaodi, HUANG Yin. Analysis of the differential compounds in Astragalus membranaceus from different geographical origins by UFLC-IT-TOF/MS[J]. Journal of China Pharmaceutical University, 2019, 50(1): 59-65. DOI: 10.11665/j.issn.1000-5048.20190108 |
[1] |
Chinese Pharmacopoeia Committee.Pharmacopoeia of the People′s Republic of China:part 1(中华人民共和国药典:一部)[S].Beijing:China Medical Science Press,2015:302-303.
|
[2] |
Fu J,Wang Z,Huang L,et al.Review of the botanical characteristics,phytochemistry,and pharmacology of Astragalus membranaceus(Huangqi)[J].Phytother Res,2014,28(9):1275-1283.
|
[3] |
Jin M,Zhao K,Huang Q,et al.Structural features and biological activities of the polysaccharides from Astragalus membranaceus[J].Int J Biol Macromol,2014,64:257-266.
|
[4] |
Li M,Wang W,Xue J,et al.Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy[J].J Ethnopharmacol,2011,133(2):412-419.
|
[5] |
Jiao J,Gai QY,Niu LL,et al.Enhanced production of two bioactive isoflavone aglycones in Astragalus membranaceus hairy root cultures by combining deglycosylation and elicitation of immobilized edible Aspergillus niger [J].J Agric Food Chem,2017,65(41):9078-9086.
|
[6] |
Shahzad M,Shabbir A,Wojcikowski K,et al.The antioxidant effects of Radix Astragali(Astragalus membranaceus and related species)in protecting tissues from injury and disease[J].Curr Drug Tar,2016,17(12):1331-1340.
|
[7] |
Liao XF,Bi XL,Xu AL,et al.Fingerprint and three constituents′ quantitative determination for Astragali Radix from different regions by HPLC-DAD-ELSD[J].J Guangdong Pharm Univ(广东药科大学学报),2018,34(5):558-563.
|
[8] |
Tian D,Li ZY,Fan SC,et al.NMR-based analysis of water soluble extracts of different Astragali Radix[J].Acta Pharm Sin(药学学报),2014,49(1):89-94.
|
[9] |
He JX,Mou QQ,Zhang JQ,et al.Rapid identification of Astragali Radix from different origins by UPLC combined with chemometrics methods [J].Chin Tradit Herbal Drugs(中草药),2017,48(1):179-184.
|
[10] |
Lai PK,Chan JY,Cheng L,et al.Isolation of anti-inflammatory fractions and compounds from the root of Astragalus membranaceus[J].Phytother Res,2013,27(4):581-587.
|
[11] |
Li J, Li F, Xu Y, et al. Chemical composition and synergistic antioxidant activities of essential oils from Atractylodes macrocephala and Astragalus membranaceus[J].Nat Prod Commun,2013,8(9):1321-1324.
|
[12] |
Guan QX, Li CD. Screening test study on seedling pattern of Astragalus membranaceus in different climate regions of Longxi(陇西不同气候区域黄芪育苗模式筛选试验研究)[J].J Chin Med Mate(中药材),2016,39(3):490-492.
|
[13] |
Liu DW,Gu CM,Yang QZ,et al.Resource surveys and suitability of origin for genuine medicinal materials,Astragalus membranaceus var.mongholicus in Inner Mongolia,China[J].Chin J Appl Ecol(应用生态学报),2016,27(3):838-844.
|
[14] |
Kai Z,Michela P,Antonio P and Annamaria P.Biological active ingredients of traditional Chinese herb Astragalus membranaceus on treatment of diabetes:a systematic review[J].Mini-Rev Med Chem,2015,15(4):315-329.
|
[15] |
Zhang LJ,Liu HK,Hsiao PC,et al.New isoflavonoid glycosides and related constituents from astragali radix(Astragalus membranaceus)and their inhibitory activity on nitric oxide production[J].J Agric Food Chem,2011,59(4):1131-1137.
|
[16] |
Nie Y,Li S,Yi Y,et al.Effects of astragalus injection on the TGFβ/Smad pathway in the kidney in type 2 diabetic mice[J].BMC Complem Altern Med,2014,14(1):148.
|
[17] |
Li W,Sun YN,Yan XT,et al.Flavonoids from Astragalus membranaceus and their inhibitory effects on LPS-stimulated pro-inflammatory cytokine production in bone marrow-derived dendritic cells[J].Arch Pharm Res,2014,37(2):186-192.
|
[18] |
Zhou R,Xu L,Ye M,et al.Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways[J].Horm Metab Res,2014,46(11):753-760.
|
[19] |
Capozzi V,Menga V,Digesu AM,et al.Biotechnological production of vitamin B2-enriched bread and pasta[J].J Agric Food Chem,2011,59(14):8013-8020.
|
[20] |
Yang B,Chen H,Stanton C,et al.Review of the roles of conjugated linoleic acid in health and disease[J].J Funct Foods,2015,15:314-325.
|
[21] |
Villacorta L,Minarrieta L,Salvatore SR,et al.In situ generation,metabolism and immunomodulatory signaling actions of nitro-conjugated linoleic acid in a murine model of inflammation[J].Redox Bio,2018,15:522-531.
|
[22] |
Wang Y,Fan X,Qu H,et al.Strategies and techniques for multi-component drug design from medicinal herbs and traditional Chinese medicine[J].Curr Top Med Chem,2012,12(12):1356-1362.
|
[23] |
Fu S,Gu Y,Jiang JQ,et al.Calycosin-7-O-β-d-glucoside regulates nitric oxide/caveolin-1/matrix metalloproteinases pathway and protects blood-brain barrier integrity in experimental cerebral ischemia-reperfusion injury[J].J Ethnopharmacol,2014,155(1):692-701.
|
[1] | YE Zhenning, WU Zhenghong, ZHANG Huaqing. Research progress of blood-brain barrier crossing strategies and brain-targeted drug delivery mediated by nano-delivery system[J]. Journal of China Pharmaceutical University, 2024, 55(5): 590-602. DOI: 10.11665/j.issn.1000-5048.2024052202 |
[2] | LUO Xuelian, WU Chengsheng, ZHA Cheng, LIU Sheng. Research progress and prospects of implantable drug delivery systems for postoperative tumor therapy[J]. Journal of China Pharmaceutical University, 2024, 55(4): 538-547. DOI: 10.11665/j.issn.1000-5048.2024040901 |
[3] | WANG Shihao, LIU Lifeng, DING Yang, LI Suxin. Research progress of pH-responsive drug delivery systems in cancer immunotherapy[J]. Journal of China Pharmaceutical University, 2024, 55(4): 522-529. DOI: 10.11665/j.issn.1000-5048.2024011902 |
[4] | YU Jiayu, LIN Zezhi, CAO Wei, ZHANG Jianjun, WEI Yuanfeng, GAO Yuan, QIAN Shuai. Research progress of bio-metal organic frameworks in drug delivery system[J]. Journal of China Pharmaceutical University, 2023, 54(1): 23-33. DOI: 10.11665/j.issn.1000-5048.20221111003 |
[5] | ZHOU Yeshu, WANG Yanmei, ZHANG Beiyuan, WU Shuaicong, YANG Lei, YIN Lifang. Research progress of inorganic nanomaterials in drug delivery system[J]. Journal of China Pharmaceutical University, 2020, 51(4): 394-405. DOI: 10.11665/j.issn.1000-5048.20200403 |
[6] | LI Haoxian, LIN Huaqing, CHEN Jingwen, WANG Liyuan. Research progress of carbon nanomaterials in cancer drug delivery[J]. Journal of China Pharmaceutical University, 2019, 50(1): 100-106. DOI: 10.11665/j.issn.1000-5048.20190114 |
[7] | FAN Qianqian, XING Lei, QIAO Jianbin, ZHANG Chenglu, JIANG Hulin. Advances in drug delivery systems for the treatment of liver fibrosis[J]. Journal of China Pharmaceutical University, 2018, 49(3): 263-271. DOI: 10.11665/j.issn.1000-5048.20180302 |
[8] | CHEN Xing, KANG Yang, WU Jun. Advances in biodegradable functional polymers based protein drug delivery system[J]. Journal of China Pharmaceutical University, 2017, 48(2): 142-149. DOI: 10.11665/j.issn.1000-5048.20170203 |
[9] | WANG Yazhe, ZHOU Jianping, DING Yang, WANG Wei. Advances in research of biomimetic drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(3): 267-273. DOI: 10.11665/j.issn.1000-5048.20140303 |
[10] | TANG Yue, KE Xue. Advances of mesoporous silica nanoparticles as drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(6): 567-572. |